News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
339,877 Results
Type
Article (19368)
Company Profile (95)
Press Release (320414)
Multimedia
Podcasts (27)
Webinars (5)
Section
Business (89314)
Career Advice (1330)
Deals (17529)
Drug Delivery (62)
Drug Development (61328)
Employer Resources (61)
FDA (9137)
Job Trends (7530)
News (174582)
Policy (15255)
Tag
Academia (1218)
Academic (1)
Accelerated approval (7)
Adcomms (15)
Allergies (71)
Alliances (17881)
ALS (78)
Alzheimer's disease (981)
Antibody-drug conjugate (ADC) (113)
Approvals (9195)
Artificial intelligence (156)
Autoimmune disease (19)
Automation (9)
Bankruptcy (139)
Best Places to Work (6369)
BIOSECURE Act (8)
Biosimilars (78)
Biotechnology (61)
Bladder cancer (76)
Brain cancer (32)
Breast cancer (339)
Cancer (2318)
Cardiovascular disease (165)
Career advice (1051)
Career pathing (16)
CAR-T (121)
CDC (8)
Cell therapy (320)
Cervical cancer (18)
Clinical research (52256)
Collaboration (542)
Compensation (290)
Complete response letters (10)
COVID-19 (2229)
CRISPR (30)
C-suite (117)
Cystic fibrosis (75)
Data (2575)
Denatured (1)
Depression (39)
Diabetes (304)
Diagnostics (3418)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (83)
Drug pricing (58)
Drug shortages (23)
Duchenne muscular dystrophy (83)
Earnings (54000)
Editorial (21)
Employer branding (11)
Employer resources (53)
Events (54630)
Executive appointments (289)
FDA (10362)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (561)
Gene editing (70)
Generative AI (11)
Gene therapy (235)
GLP-1 (722)
Government (2425)
Grass and pollen (4)
Guidances (165)
Healthcare (9672)
HIV (36)
Huntington's disease (20)
IgA nephropathy (34)
Immunology and inflammation (113)
Immuno-oncology (6)
Indications (33)
Infectious disease (2333)
Inflammatory bowel disease (104)
Inflation Reduction Act (5)
Influenza (46)
Intellectual property (79)
Interviews (244)
IPO (10221)
IRA (19)
Job creations (1457)
Job search strategy (910)
Kidney cancer (14)
Labor market (35)
Layoffs (258)
Leadership (15)
Legal (2487)
Liver cancer (54)
Longevity (7)
Lung cancer (341)
Lymphoma (177)
Machine learning (2)
Management (17)
Manufacturing (196)
MASH (80)
Medical device (6414)
Medtech (6414)
Mergers & acquisitions (7752)
Metabolic disorders (736)
Multiple sclerosis (79)
NASH (17)
Neurodegenerative disease (83)
Neuropsychiatric disorders (23)
Neuroscience (1483)
NextGen: Class of 2025 (2662)
Non-profit (1852)
Now hiring (13)
Obesity (384)
Opinion (109)
Ovarian cancer (81)
Pain (78)
Pancreatic cancer (92)
Parkinson's disease (149)
Partnered (11)
Patents (156)
Patient recruitment (122)
Peanut (39)
People (15721)
Pharmaceutical (29)
Pharmacy benefit managers (4)
Phase I (14828)
Phase II (25771)
Phase III (16814)
Pipeline (1412)
Policy (74)
Postmarket research (1587)
Preclinical (4982)
Press Release (30)
Prostate cancer (116)
Psychedelics (27)
Radiopharmaceuticals (159)
Rare diseases (310)
Real estate (1743)
Recruiting (30)
Regulatory (12085)
Reports (35)
Research institute (1164)
Resumes & cover letters (257)
Rett syndrome (9)
RNA editing (3)
RSV (30)
Schizophrenia (71)
Series A (84)
Series B (64)
Service/supplier (6)
Sickle cell disease (45)
Special edition (17)
Spinal muscular atrophy (134)
Sponsored (22)
Startups (1348)
State (2)
Stomach cancer (14)
Supply chain (39)
Tariffs (30)
The Weekly (26)
Vaccines (549)
Venture capital (21)
Weight loss (245)
Women's health (25)
Worklife (11)
Date
Today (67)
Last 7 days (251)
Last 30 days (1235)
Last 365 days (20582)
2025 (11271)
2024 (22022)
2023 (24445)
2022 (29984)
2021 (32062)
2020 (30534)
2019 (22702)
2018 (17293)
2017 (17516)
2016 (15308)
2015 (18682)
2014 (13373)
2013 (9816)
2012 (10616)
2011 (11095)
2010 (9732)
Location
Africa (409)
Alabama (35)
Alaska (1)
Arizona (71)
Arkansas (4)
Asia (22072)
Australia (3954)
California (4780)
Canada (1502)
China (513)
Colorado (184)
Connecticut (225)
Delaware (138)
Europe (49118)
Florida (645)
Georgia (162)
Idaho (27)
Illinois (318)
India (15)
Indiana (223)
Iowa (10)
Japan (171)
Kansas (49)
Kentucky (24)
Louisiana (9)
Maine (37)
Maryland (605)
Massachusetts (3497)
Michigan (114)
Minnesota (221)
Mississippi (3)
Missouri (48)
Montana (14)
Nebraska (7)
Nevada (52)
New Hampshire (40)
New Jersey (1432)
New Mexico (4)
New York (1421)
North Carolina (558)
North Dakota (3)
Northern California (2111)
Ohio (118)
Oklahoma (1)
Oregon (17)
Pennsylvania (966)
Puerto Rico (16)
Rhode Island (14)
South America (569)
South Carolina (11)
Southern California (1884)
Tennessee (45)
Texas (720)
United States (17049)
Utah (130)
Virginia (94)
Washington D.C. (37)
Washington State (397)
West Virginia (1)
Wisconsin (34)
339,877 Results for "2".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
J&J Raises 2025 Outlook as Oncology and Neuroscience Drive Q2 Growth
Johnson & Johnson kicked off Q2 2025 pharma earnings season with a bang Wednesday, adding $2 billion to the midpoint of its full-year sales estimate after reporting almost 6% sales growth in the quarter.
July 16, 2025
·
1 min read
·
Nick Paul Taylor
Job Trends
Bonus Episode: Q1 2025 Job Market Update
In this bonus episode,
BioSpace’s
Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q2 job market performance, layoffs and wider employment trends and policies impacting the biopharma workforce.
July 15, 2025
·
1 min read
·
Angela Gabriel
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
June 24, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease
July 10, 2025
·
6 min read
Press Releases
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
July 14, 2025
·
9 min read
Press Releases
Akeso’s First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in ‘IO+ADC’ 2.0 Strategy
July 3, 2025
·
2 min read
Press Releases
A2 Bio Announces First Patient Dosed in DENALI-1 Phase 1/2 Clinical Study of A2B395, a Novel Allogeneic Precision CAR T Cell Therapy for Patients with Solid Tumors that Express EGFR
June 26, 2025
·
5 min read
Press Releases
China’s HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC
May 29, 2025
·
2 min read
Press Releases
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization
June 10, 2025
·
7 min read
Press Releases
Metabolon’s Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D)
July 2, 2025
·
4 min read
1 of 33,988
Next
